Form 4 for VERA Vera Therapeutics, Inc.
Accepted 2022-10-06 00:00:00 ET · period of report 2022-10-05 · accession 0001209191-22-052972 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-06 | 2022-10-05 | VERA | Curley Joanne | Chief Development Off | S - Sale | $21.64 | -988 | 27.8K | -3% | -$21.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-10-05 | S | D | 988 | $21.64 | 27,809 | D | — | — |